Gustavo Mostoslavsky

Gustavo Mostoslavsky

Auto-generated profile, based on publicly available information

Gustavo Mostoslavsky

Affiliations Center for Regenerative Medicine (CReM), Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, United States of America, Department of Medicine, Section of Gastroenterology; Department of Virology, Immunology, and Microbiology. Boston University Chobanian & Avedisian School of Medicine, Boston Massachusetts, United States of America

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2007 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
PCPaolo De Coppi
Paolo De Coppi
GBGeorg Bartsch
Georg Bartsch
MSM Minhaj Siddiqui
M Minhaj Siddiqui
TXTao Xu
Tao Xu
CSCesar C Santos
Cesar C Santos
Anthony AtalaAnthony Atala
Anthony Atala

1 January 2006 in Cell
Verified
Journal Article
Closed access
RMRaul Mostoslavsky
Raul Mostoslavsky
KCKatrin F. Chua
Katrin F. Chua
DLDavid B. Lombard
David B. Lombard
WPWendy W. Pang
Wendy W. Pang
MFMiriam R. Fischer
Miriam R. Fischer
FAFrederick W. Alt
Frederick W. Alt

1 February 2011 in Cell Stem Cell
Verified
Journal Article
Closed access
KKKian Peng Koh
Kian Peng Koh
AYAkiko Yabuuchi
Akiko Yabuuchi
SRSridhar Rao
Sridhar Rao
YHYun Huang
Yun Huang
KCKerrianne Cunniff
Kerrianne Cunniff
ARAnjana Rao
Anjana Rao

1 March 2009 in Stem Cells
Verified
Journal Article
Open access
PDF file
CSCesar A. Sommer
Cesar A. Sommer
MSMatthias Stadtfeld
Matthias Stadtfeld
GMGeorge J. Murphy
George J. Murphy
KHKonrad Hochedlinger
Konrad Hochedlinger
DKDarrell N. Kotton
Darrell N. Kotton
GMGustavo Mostoslavsky
Gustavo Mostoslavsky
Induced pluripotent stem (iPS) cells can be generated using retroviral vectors expressing Oct4, Klf4, Sox2, and cMyc. Most prior studies have required multiple retroviral vectors for reprogramming, resulting in high numbers of genomic integrations in iPS cells and limiting their use for therapeutic applications. Here we describe the use of a single lentiviral vector expressing a “stem cell cassette” composed of the four transcription factors and a combination of 2A peptide and internal ribosome entry site technology, generating iPS cells from postnatal fibroblasts. iPS cells generated in this manner display embryonic stem cell-like morphology, express stem cell markers, and exhibit in vivo pluripotency, as evidenced by their ability to differentiate in teratoma assays and their robust contribution to mouse chimeras. Combining all factors into a single transcript achieves the most efficient reprogramming system to date and allows derivation of iPS cells with a single viral integration. The use of a single lentiviral vector for reprogramming represents a powerful laboratory tool and a significant step toward the application of iPS technology for clinical purposes.

26 February 2009 in Nature
Verified
Journal Article
Closed access
PDF file
AMAkiko Mammoto
Akiko Mammoto
KCKip M Connor
Kip M Connor
TMTadanori Mammoto
Tadanori Mammoto
CYChong Wing Yung
Chong Wing Yung
DHDongeun Huh
Dongeun Huh
DIDonald E Ingber
Donald E Ingber

1 July 2010 in Cell Stem Cell
Verified
Journal Article
Closed access
JSJudith Staerk
Judith Staerk
MDMeelad M. Dawlaty
Meelad M. Dawlaty
QGQing Gao
Qing Gao
DMDorothea Maetzel
Dorothea Maetzel
JHJacob Hanna
Jacob Hanna
RJRudolf Jaenisch
Rudolf Jaenisch